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Nonpharmacologic Treatments for Childhood
Constipation: Systematic Review
abstract
OBJECTIVE: To summarize the evidence and assess the reported qual-
ity of studies concerning nonpharmacologic treatments for childhood
constipation, including ﬁber, ﬂuid, physical movement, prebiotics, pro-
biotics, behavioral therapy, multidisciplinary treatment, and forms of
alternative medicine.
METHODS: We systematically searched 3 major electronic databases
and reference lists of existing reviews. We included systematic reviews
and randomized controlled trials (RCTs) that reported on nonpharma-
cologic treatments. Two reviewers rated the methodologic quality
independently.
RESULTS: We included 9 studies with 640 children. Considerable het-
erogeneity across studies precluded meta-analysis. We found no RCTs
for physical movement, multidisciplinary treatment, or alternative
medicine. Some evidence shows that ﬁber may be more effective than
placebo in improving both the frequency and consistency of stools and
in reducing abdominal pain. Compared with normal ﬂuid intake, we
found no evidence that water intake increases or that hyperosmolar
ﬂuid treatment is more effective in increasing stool frequency or de-
creasing difﬁculty in passing stools. We found no evidence to recom-
mend the use of prebiotics or probiotics. Behavioral therapy with lax-
atives is not more effective than laxatives alone.
CONCLUSIONS: There is some evidence that ﬁber supplements are
more effective than placebo. No evidence for any effect was found for
ﬂuid supplements, prebiotics, probiotics, or behavioral intervention.
There is a lack of well-designed RCTs of high quality concerning non-
pharmacologic treatments for children with functional constipation.
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Chronic constipation is a common
problem in childhood; the estimated
prevalence is 3% in the Western
world.1 It is a debilitating condition
characterized by infrequent painful
defecation, fecal incontinence, and ab-
dominal pain. It causes distress to the
child and family and can result in se-
vere emotional disturbances and fam-
ily discord.
The cause of constipation is multifac-
torial and is not well understood. Cri-
teria for a deﬁnition of functional con-
stipation vary widely and are based
mostly on a variety of symptoms, in-
cluding decreased frequency of bowel
movements, fecal incontinence, and a
change in stool consistency.2
Constipation is difﬁcult to treat for the
majority of patients and indeed is a
long-lasting problem. Approximately
50% of all children who were moni-
tored for 6 to 12 months were found to
recover and successfully discontinued
laxative therapy.3 A study in a tertiary
hospital showed that, despite intensive
medical and behavioral therapy, 30%
of patients who developed constipa-
tion before the age of 5 years contin-
ued to have severe complaints of
constipation, infrequent painful defe-
cation, and fecal incontinence beyond
puberty.4
The ﬁrst step in treatment consists of
education, dietary advice, and behav-
ioral modiﬁcations.2 If these are not ef-
fective, then laxatives are prescribed.
Although there is a lack of placebo-
controlled trials showing the effective-
ness of laxatives, their use in clinical
practice is widely accepted.5 The
chronic nature of the disease, in com-
bination with a lack of clear effects of
laxatives and parents’ general fear of
adverse effects with daily medication
use, is probably why 36.4% of children
with functional constipation use some
form of alternative treatment (eg,
acupuncture, homeopathy, mind-body
therapy, musculoskeletal manipula-
tions such as osteopathic and chiro-
practic manipulations, and spiritual
therapies such as yoga).6
To date, no systematic reviews of the
effectiveness of nonpharmacologic
treatments (ﬁber, ﬂuid, physical move-
ment, prebiotics and probiotics, be-
havioral therapy, multidisciplinary
treatment, and forms of alternative
medicine) for childhood constipation
have been published. Furthermore, the
published guidelines for the treatment
of functional constipation are based
on reviews of the literature that did not
apply a systematic literature search,
did not incorporate quality assess-
ment of studies, or used a language
restriction.5,7–9 Therefore, it was our
aim to investigate systematically and
to summarize the quantity and quality
of all current evidence on the effects of
ﬁber, ﬂuid, physical movement, prebi-
otics, probiotics, behavioral therapy,
multidisciplinary treatment, and alter-
native medicine (including acupunc-
ture, homeopathy, mind-body therapy,
musculoskeletal manipulations such
as osteopathic and chiropractic ma-
nipulations, and spiritual therapies




The Embase, Medline, and PsycINFO da-
tabases were searched by a clinical li-
brarian from inception to January
2010. The key words used to describe
the study population were “constipa-
tion,” “obstipation,” “fecal inconti-
nence,” “coprostasis,” “encopresis,”
and “soiling.” These words were com-
bined with key words referring to the
different types of interventions that
were investigated in the present re-
view. Additional strategies for identify-
ing studies included searching the ref-
erence lists of review articles and
included studies. No language restric-
tion was applied. The full search strat-
egy is available from the authors.
Study Selection, Data Extraction,
and Methodologic Quality
Two reviewers (Drs Tabbers and Bo-
luyt) independently screened the ab-
stracts of all identiﬁed published arti-
cles for eligibility. Inclusion criteria
were as follows. (1) The study was a
systematic review or randomized con-
trolled trial (RCT) and contained 10
subjects per arm. (2) The study popu-
lation consisted of children 0 to 18
years of age with functional constipa-
tion. (3) A deﬁnition of constipation
was provided. (4) The study evaluated
the effect of a nonpharmacologic
treatment, compared with placebo, no
treatment, another alternative treat-
ment, or medication, for constipation.
(5) Nonpharmacologic treatments in-
cluded ﬁber, ﬂuid, physical movement,
prebiotics, probiotics, behavioral ther-
apy, multidisciplinary treatment, and
alternative medicine. (6) Outcome
measures were either establishment
of normal bowel habits (increase in
defecation frequency and/or decrease
in fecal incontinence frequency) or
treatment success as deﬁned by the
authors of the study, adverse effects,
and costs. All potentially relevant stud-
ies were retrieved as full articles. Arti-
cles concerning children with organic
causes of constipation and children
with exclusively functional, nonreten-
tive, fecal incontinence were excluded.
Data were extracted by 2 reviewers
(Drs Tabbers and Boluyt), who used
structured data extraction forms. Two
reviewers independently rated the
methodologic quality of the included
studies by using a standardized list de-
veloped for RCTs, that is, the Delphi list
(Table 1). Disagreements in any of the
aforementioned steps were resolved
through consensus, when possible, or
a third person (Prof Dr Benninga)
made the ﬁnal decision.
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Data Analyses
Methodologic quality scores were cal-
culated as a percentage of the maxi-
mal quality score on the Delphi list.
High quality was deﬁned as a score of
60% (ie, 6 points) and low quality
as a score of60%.10 Table 1 presents
the Delphi list.
RESULTS
Study Selection and Methodologic
Quality Assessment
We included 9 studies with survey data
(collected in 1986–2008) for 640 chil-
dren. The sample sizes of the studies
ranged from 3111 to 134.12 Table 2 pres-
ents the characteristics of the studies
included. No RCTs on the effects of
physical movement, multidisciplinary
treatment, or alternative medicine
(acupuncture, homeopathy, mind-body
therapy, musculoskeletal manipula-
tions such as osteopathic and chiro-
practic manipulations, or spiritual
therapies such as yoga) for children
with constipation were found. All stud-
ies were hospital-based; 3 were con-
ducted in a general pediatric depart-
ment14,18,19 and 6 were conducted in a
pediatric gastroenterology depart-
ment.11–13,15–17 The studies were highly
diverse with regard to the partici-
pants, interventions, and outcome
measures; therefore, a meta-analysis
of all included studies could not be per-
formed. Consequently, we discuss all
studies separately, including their
most important methodologic short-
comings. Only 5 studies (56%) had




One systematic review was found in
which ﬁber was one of the options
evaluated.5 The authors included 2
RCTs comparing the effects of ﬁber
versus placebo.11,13 An additional
search yielded 1 relevant RCT compar-
ing ﬁber versus lactulose.14 All 3 RCTs
are discussed brieﬂy.
Fiber Versus Placebo
A small crossover RCT of low quality
compared ﬁber (glucomannan) versus
placebo among children with func-
tional constipation.11 The study used
an adequate randomization proce-
dure, but no information on blinding of
the outcome assessor was provided
and an intention-to-treat analysis was
not performed. Other major shortcom-
ings that might have caused bias were
the unclear deﬁnition of constipation
and the unexplained high rate of loss
to follow-up monitoring of 32%. Consti-
pation was deﬁned as a delay or difﬁ-
culty in defecation for2 weeks. If lax-
ative therapy was instituted, then all
children continued to receive the same
amount of laxatives during the study.
Patients ﬁlled out a daily bowel diary.
Physician-rated treatment success
was deﬁned as 3 bowel movements
per week and 1 episode of encopre-
sis every 3 weeks, with no abdominal
pain. Remarkably, the initial daily ﬁber
intake was low for 71% of all children.
Before crossover, the RCT found that the
proportion of children with 3 bowel
movements per week and abdominal
pain was signiﬁcantly smaller in the ﬁ-
ber group, compared with the placebo
group. The proportion of children who
were rated by their physicians as being
treated successfully and by their par-
ents as experiencing improvement was
signiﬁcantly larger after treatment with
ﬁber, compared with placebo.
The second RCT, of high quality, com-
pared ﬁber (a cocoa husk supplement)
and placebo among otherwise-healthy
children.13 The study fulﬁlled most of
the criteria for validity, such as ade-
quate randomization and blinding and
a low dropout rate (20%) distributed
equally over the 2 groups. Children
ﬁlled out a daily diary. The difference in
mean basal dietary ﬁber intake was
not statistically signiﬁcant. Moreover,
the mean basal dietary ﬁber intake
was close to the value recommended
for children (age plus 5 g) in both
groups (12.3 g/day with ﬁber and 13.4
g/day with placebo; P not reported).13
No signiﬁcant difference between the
groups in the change in total colon
transit time or in the mean defecation
frequency per week was found. Signif-
icantly more children (or parents) re-
ported a subjective improvement in
stool consistency but not a subjective
improvement in pain during defeca-
tion with ﬁber, compared with pla-
cebo. A subanalysis of data for 12 chil-
dren with a total basal intestinal
transit time of 50th percentile
TABLE 1 Delphi List
Item No. Question
Study population
D1 Was a method of randomization performed?
D2 Was the allocation of treatment concealed?
D3 Were the groups similar at baseline regarding the most important prognostic
indicators (age, gender, disease duration, and disease severity)?
D4 Were both inclusion and exclusion criteria speciﬁed?
Blinding
D5 Was the outcome assessor blinded?
D6 Was the care provider blinded?
D7 Was the patient blinded?
Analysis
D8 Were point estimates and measures of variability presented for the primary outcome
measures?
D9 Did the analysis include an intention-to-treat analysis?
D10 Is the withdrawal/drop-out rate20% and equally distributed?
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showed that the change in total intes-
tinal transit time was signiﬁcantly
greater with ﬁber, compared with pla-
cebo (38.1 hours [95% conﬁdence in-
terval: 67.9 to 8.4 hours]; P 
.015).
Fiber Versus Lactulose
A low-quality RCT compared ﬁber with
lactulose for 8 weeks, followed by 4
weeks of weaning, among otherwise-
healthy children with constipation.14
The study used an adequate random-
ization procedure, but no information
on blinding of the outcome assessor
was provided, no intention-to-treat
analysis was performed, and the drop-
out rate was high and not equally dis-
tributed. Polyethylene glycol (macro-
gol 3350) was added if no clinical
improvement was observed after 3
weeks. The RCT found no signiﬁcant dif-
ference between the groups in the
numbers of children with 1 fecal in-
continence episode per week or in the
mean scores (scale: 0 not at all, 1
sometimes, 2 often, 3 continuous)
for people with abdominal pain or ﬂat-
ulence at weeks 3 and 8 of follow-up
monitoring. The RCT also found no sig-
niﬁcant difference between the groups
in the necessity for step-upmedication
or in taste scores, but absolute num-
bers were not reported. All included
RCTs reported no adverse effects of
ﬁber.
Fluid
One low-quality RCT that compared 3
groups, that is, 50% water intake in-
crease, hyperosmolar (600mOsm/L)
supplemental ﬂuid treatment, and nor-
mal ﬂuid intake, met our inclusion cri-
teria.15 No information was provided
about randomization, blinding, or the
rate of loss to follow-up monitoring.
Furthermore, no statistical assess-
ment was conducted, and data were
reported incompletely. Similar stool
frequencies were found at 3 weeks for
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respect to difﬁculty in passing stools
were found (signiﬁcance not as-
sessed). Stool consistencies were re-
ported only for the water increase
group and the hyperosmolar ﬂuid
group and were similar at 3 weeks
(signiﬁcance was not assessed).
Prebiotics
One systematic review was found that
included 1 small, high-quality RCT com-
paring a standard formula (Nutrilon 1
[Nutricia Nederland BV, Zoetermeer,
Netherlands]) with a formula with a
high concentration of sn-2 palmitic
acid, a mixture of prebiotic oligosac-
charides, and partially hydrolyzed
whey protein (Nutrilon Omneo [Nutri-
cia Nederland BV]).5,16 That study ful-
ﬁlled most of the criteria for validity,
such as adequate randomization and
blinding, and inclusion and exclusion
criteria were both clearly speciﬁed;
however, the study was designed orig-
inally as a crossover trial but, because
of the high rate of loss to follow-up
monitoring (37% after 6weeks), the re-
sults of the ﬁrst treatment period only
were analyzed. No signiﬁcant differ-
ence between the 2 groups in themean
defecation frequency per week after 3
weeks was found. A difference in im-
provement of hard stools to soft stools
in favor of the prebiotic group was
found; however, this difference was
not statistically signiﬁcant.
Probiotics
One systematic review was found that
included 2 RCTs evaluating the effects
of probiotics.5,17,18 The ﬁrst high-quality
trial was conducted to determine
whether Lactobacillus rhamnosus GG
was an effective adjunct to lactulose
for treating constipation in children.
The study fulﬁlled all criteria for valid-
ity. Childrenwith constipation received
1 mL/kg per day of 70% lactulose plus
109 colony-forming units of L rhamno-
sus GG or 1 mL/kg per day of 70% lac-
tulose plus placebo twice daily for 12
weeks.17 There were no signiﬁcant dif-
ferences in rates of treatment success
(deﬁned as 3 bowel movements per
week with no episodes of fecal inconti-
nence) at 12 and 24 weeks between the
L rhamnosus GG group and the pla-
cebo group. No signiﬁcant differences
between the probiotic group and the
placebo group with respect to the
numbers of episodes of fecal soiling
per week at 12 weeks, frequencies of
straining at 12 weeks, and proportions
of children using laxatives at 24 weeks
were found.
The second high-quality RCT compared
magnesium oxide with the probiotic
Lactobacillus casei rhamnosus or pla-
cebo.18 The placebo group included
only 9 patients and therefore is not dis-
cussed. The study fulﬁlled almost all
important criteria for validity. Similar
differences in defecation frequencies
were found for the probiotic group and
the magnesium oxide group. The clini-
cal relevance of these differences in
defecation frequencies is unclear. The
RCT also found that probiotics signiﬁ-
cantly reduced abdominal pain, com-
pared with osmotic laxatives. It found
no signiﬁcant difference in rates of
treatment success (deﬁned as 3
spontaneous defecations per week
with no episodes of fecal incontinence
by the fourth week) between probiot-
ics and osmotic laxatives, compared
with placebo. The RCT also found simi-
lar rates of fecal incontinence (statis-
tical signiﬁcance between groups was
not assessed). It found no signiﬁcant
difference in the proportions of hard
stools between probiotics and osmotic
laxatives. Both trials did not report any
adverse events for the groups receiv-
ing probiotics.
Behavioral Therapy
We found 1 systematic review (search
date from inception to 2006, including
18 RCTs and 1186 children; 17 of the 18
RCTs investigated children with func-
tional fecal incontinence and therefore
are not discussed) that compared be-
havioral and/or cognitive interven-
tions, with or without other treat-
ments, for the management of fecal
incontinence attributable to organic or
functional constipation in children.20
An additional search found 42 studies,
of which 1 RCT met our inclusion
criteria.12
The systematic review included 1 low-
quality RCT that compared behavioral
interventions (education) and a sys-
tem of rewards from a pediatrician
with monthly psychotherapy with a
child psychiatrist.19 The method of ran-
domization was not stated clearly.
Blinding in this case was not possible
for the care provider or the patient.
However, no information on whether
the outcome assessor was blinded
was provided. The analysis did not in-
clude an intention-to-treat analysis,
and the dropout rate was 20%. All
children were seen every 6 weeks for
periods from 3 months to 1 year. At
every visit with the child psychiatrist,
the mother and the child were seen
separately for 15 to 30 minutes. The
authors did not provide any clear de-
tails about this psychotherapy. A total
of 22 children experienced cures (5
bowel movements per week with no
episodes of fecal incontinence per
week and no use of laxatives), 8 chil-
dren experienced improvement (3
bowel movements per week with 1
episode of fecal incontinence per
week), and 16 did not experience im-
provement (3 bowel movements per
week or 1 episode of fecal inconti-
nence per week). However, it was not
clear from the study how many chil-
dren in each group experienced cures,
improvement, or no improvement.
One subsequent high-quality RCT com-
pared behavioral therapy by a child
psychologist (learning process to re-
duce phobic reactions related to defe-
cation, which consisted of 5 sequential
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steps, ie, know, dare, can, will, and do)
and conventional treatment by a pedi-
atric gastroenterologist (education,
diary, and toilet training with a reward
system) over 22weeks (12 visits).12 The
study fulﬁlled all important criteria for
validity. Both groups used similar lax-
ative therapy. Although statistically
signiﬁcant increases in defecation fre-
quency and statistically signiﬁcant re-
ductions in fecal incontinence epi-
sodes were found in both groups, no
signiﬁcant differences between the
groups in defecation frequencies at 22
weeks and 6 months or in episodes of
fecal incontinence were seen. Further-
more, no signiﬁcant differences be-
tween the groups with respect to suc-
cess rates were found. After 6 months,
the proportion of children with behav-
ioral problems was signiﬁcant smaller
in the behavioral therapy group, com-
pared with the conventional treatment
group (11.7% vs 29.2%; P .039).
DISCUSSION
This systematic review clearly shows a
lack of adequately powered, high-
quality studies evaluating the thera-
peutic role of nonpharmacologic treat-
ments. Although the ﬁrst step of
treatment consists of dietary advice
(adequate ﬁber and ﬂuid intake) and
behavioral interventions, no evidence
from trials suggesting any effect for
ﬂuid supplements or behavioral ther-
apy was found. Only marginal evidence
showing that ﬁber supplements are
more effective than placebo in the care
of children with constipation exists.
Also, no evidence was found for prebi-
otics or probiotics. Moreover, no RCTs
involving physical movement, multidis-
ciplinary treatment, or alternative
medicine (including acupuncture,
homeopathy, mind-body therapy, mus-
culoskeletal manipulations such as os-
teopathic and chiropractic manipula-
tions, and spiritual therapies such as
yoga) were found.
The results of the few, mainly under-
powered, studies included in this re-
view should be interpreted cautiously,
given the lack of uniform deﬁnitions
used for constipation and the meth-
odologic limitations of the published
studies. Each included trial used a dif-
ferent study design with respect to the
duration of the study, the number of
visits, the method of blinding, the out-
come measures, and follow-up moni-
toring. Future studies with children
with constipation should be conducted
not only in tertiary care settings but
also in primary and secondary care
settings, with standardized protocols
as suggested by experts in both adult
and pediatric functional gastrointesti-
nal disease. With improvements in the
quality of research methods, the qual-
ity of care should improve through ear-
lier and better recognition of constipa-
tion and improved diagnostic and
therapeutic strategies. Therefore, in-
volved researchers should use homo-
geneous patient populations and out-
come measures, including standard
deﬁnitions as described in the Rome III
criteria.21,22 Because functional consti-
pation is a long-lasting problem in
many cases, long-term follow-up mon-
itoring is necessary for better under-
standing of the clinical course of the
disease.4 Growing up with a chronic
disorder may impede the child’s devel-
opment and may affect psychological
and psychosocial functioning. There-
fore, quality-of-life assessments, using
baseline generic and before/after
disease-speciﬁc quality-of-life instru-
ments, are important secondary out-
come measures.20
High success rates for placebo (60%)
often are reported for pediatric and
adult patients with functional gastro-
intestinal disorders.23,24 Despite the
high response rates for placebo, there
is a paucity of placebo-controlled stud-
ies with large patient samples for pe-
diatric patients with constipation. It is
well known that patients given placebo
have expectations of future responses,
which inﬂuences outcomes. In fact, the
reported responses to placebo in RCTs
might point toward the natural course
of disease, ﬂuctuations in symptoms,
regression to the mean, or effects of
other simultaneous treatments. There-
fore, studies with such children that
include groups that receive no treat-
ment, to control for natural history
and regression to the mean and to
make the studies more likely to deter-
mine a real placebo effect, are
necessary.
Despite the high levels of use of non-
pharmacologic treatments, we did not
ﬁnd any comparative trial evaluating
their efﬁcacy in childhood constipa-
tion.6 Widespread use of therapies
such as homeopathy, massage ther-
apy, and acupuncture with no evidence
of efﬁcacy emphasizes the vulnerable
disposition of patients, who at times
seek out such treatments because of
inadequate effects achieved with con-
ventional treatments and the miscon-
ception that complementary medicine
(forms of alternative medicine) lacks
adverse effects and may not interfere
with prescribed medications.6 In addi-
tion, use of these interventions is
costly. A study involving adults with
functional gastrointestinal diseases in
the United States showed that one-
third of the patients used some com-
plementary or alternative medicine
(most used were ginger, massage
therapy, and yoga); the median yearly
cost was $200.25
The main unanswered question is why
well-designed trials concerning fre-
quently used complementary treat-
ments are lacking for one of the most
prevalent, frustrating, long-lasting, pe-
diatric gastrointestinal disorders.1,4,6
There are some explanations. Lack of
funding may play an important role. Al-
though governments and private foun-
dations are increasingly investigating
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nonpharmacologic treatments, the
available budgets are still very small,
in comparison with the budgets for
conventional treatment research.6
Furthermore, blinding patients to their
treatment arm could be difﬁcult in
some nonpharmacologic studies, such
as studies assessing the efﬁcacy of
massage-based therapies. As in every
systematic review, there is a risk that
not all relevant studies were included.
To minimize this risk, we performed a
sensitive literature searchwithout lan-
guage restrictions.
CONCLUSIONS
We found only some evidence that ﬁber
supplements were more effective than
placebo in the care of children with
constipation. This study clearly shows
that there is a lack of well-designed
RCTs of high quality concerning non-
pharmacologic treatments for chil-
dren with functional constipation.
Therefore, we recommend additional,
well-designed RCTs of high quality to
investigate the efﬁcacy, safety, and
cost-effectiveness of the different
treatment forms investigated in this
review, using homogeneous patient
populations and outcome measures,
including standard deﬁnitions as de-
scribed in the Rome III criteria.
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